CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation
Medicine, Inc. (NASDAQ:FMI) today announced that financial results
for the company's second quarter ended June 30, 2017 will be released on
Tuesday, August 1, 2017. The management team will host a conference call
on Tuesday, August 1, 2017, at 4:30 p.m. ET to discuss the company's
financial results and recent developments. The call can be accessed by
dialing 1-877-270-2148 (domestic) or 1-412-902-6510 (international) five
minutes prior to the start of the call. A passcode is not required to
access the live call from either number. A replay of the conference call
will be available until August 15, 2017 and can be accessed by dialing
1-412-317-0088 and providing the passcode 10110537.

The live, listen-only webcast of the conference call may be accessed by
visiting the investors’ section of the company's website at
investors.foundationmedicine.com. A replay of the webcast will be
available shortly after the conclusion of the call and will be archived
on the company's website for two weeks following the call.

About Foundation MedicineFoundation Medicine (NASDAQ:FMI)
is a molecular information company dedicated to a transformation in
cancer care in which treatment is informed by a deep understanding of
the genomic changes that contribute to each patient’s unique cancer. The
company offers a full suite of comprehensive genomic profiling assays to
identify the molecular alterations in a patient’s cancer and match them
with relevant targeted therapies, immunotherapies and clinical trials.
Foundation Medicine's molecular information platform aims to improve
day-to-day care for patients by serving the needs of clinicians,
academic researchers and drug developers to help advance the science of
molecular medicine in cancer. For more information, please visit http://www.FoundationMedicine.com
or follow Foundation Medicine on Twitter (@FoundationATCG).

Foundation Medicine® is a registered
trademark of Foundation Medicine, Inc.